Researchers have developed a new model to track inflammation-driven blood clots that can cause complications in sickle cell ...

Fibrinolytic therapy, also known as thrombolytic therapy, is used to lyse acute blood clots by activating plasminogen, resulting in the formation of plasmin, which cleaves the fibrin cross-links ...

This came after Intas Pharmaceuticals presented the proposal to conduct phase III Clinical trial titled: “A Single Group, Non ...